3rd Orphan Drug designation for Toripalimab 3rd Orphan Drug designation for Toripalimab

Here is the original post:
Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma